FAKTOR OPTIONSSCHEIN - MERCK & CO. | Delayed Deutsche Boerse AG 10:03:14 2024-05-24 am EDT | ||
| 1.35 EUR | +0.75% |
|
| 1 month | -17.79% | ||
| 3 months | -17.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 1.35 | +0.75% |
| 24-05-23 | 1.34 | +0.75% |
| 24-05-22 | 1.33 | -1.48% |
| 24-05-21 | 1.35 | +2.27% |
| 24-05-20 | 1.32 | -2.22% |
Delayed Quote Deutsche Boerse AG
Last update May 24, 2024 at 10:03 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UL5PXQ |
| ISIN | DE000UL5PXQ5 |
| Date issued | 2023-07-14 |
| Strike | 157.3 $ |
| Maturity | Unlimited |
| Parity | 17.83 : 1 |
| Emission price | 5.25 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.27 € |
|---|---|
| Lowest since issue | 1.27 € |
| Spread | 0.03 € |
| Spread % | 2.19% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.1
USD
Average target price
141.9
USD
Spread / Average Target
+8.23%
- Stock Market
- Certificates
- Certificat
